Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 8th Asia Pacific STD and Infectious Diseases Congress Hotel Radisson | Tokyo Japan .

Day 1 :

Keynote Forum

Mehrnaz Ajorloo

Shahid Beheshti University of Medical Sciences, Iran

Keynote: New approaches to cervical cancer treatment by reformed sperms

Time : 10:15 - 11:00

OMICS International STD Asia Pacific 2018 International Conference Keynote Speaker Mehrnaz Ajorloo photo

Mehrnaz Ajorloo is a Biotechnologist working in Avicenna Research Center, Tehran, Iran. She has completed her Medical studies in Genetic Engineering at Rudehen Azad University, Tehran, Iran. She has published more than 10 papers in reputed journals and has been serving as an Editorial Board Member of repute.


Cervical cancer is a type of cancer that started from the cervix of rheum and it spreads to other parts of the textures of the target or other organs. Across the world, this type of cancer is the fourth leading cause of death in women. According to the global statistics out of every 528000, 266000 deaths have been reported that occurs most in developing countries. Chemotherapy and radiotherapy are commonly used in this cancer as chemotherapy-based treatments will have very serious side effects for the body and may cause serious damage to healthy cells close to the tumor during the removal of cancer cells. According to researches and expert studies on effective methods for the delivery of therapeutic drugs to tumors and adequate knowledge of the structure and function of sperms, these mobile cells can be used to deliver medications to the tumor site. This method has many advantages, including the packaging of the drug for treating cervical cancer that this makes it not to dilute medications in body fluids and do not leak out and also the desired medication keeps away from existing enzymes and they do not stimulate the immune response. Another advantage of this treatment method is that sperms are inherently motile and could transmit them exactly to the place of the tumors by magnetic panels that added to these drug carriers until according to their normal function release the drug into tumors in the cervix, this causes the drug to reach deeper cancer cells in the masses. This therapeutic mechanism has been very low risk and currently it is under experimental discussion and research.